Peake: VA Research Will Benefit Veterans, Others
WASHINGTON, March 13 /PRNewswire-USNewswire/ -- A Department of Veterans Affairs (VA) research project, which may lead to development of a vaccine to prevent Salmonella poisoning, was aboard the NASA space shuttle that launched March 11.
"This space flight is an exciting step in the development of a Salmonella vaccine that will benefit not only our nation's veterans, but all mankind," said Secretary of Veterans Affairs Dr. James B. Peake. "This is a great example of VA working with the private and public sectors on vital research to create a life-saving advancement."
The space shuttle Endeavour is transporting research material to the International Space Station. The research will be used by VA investigators and other researchers to develop a Salmonella vaccine with the potential to save lives and billions of dollars.
The project came about through the teaming of VA researchers with investigators from the National Space Biomedical Research Institute, Duke University Medical Center, the University Colorado at Boulder, Germany's Max Planck Institute; and a commercial industry sponsor, SPACEHAB Inc.
Previous work has identified several genes that weaken Salmonella when they are removed. One of these weakened strains may be suitable to use in a vaccine, but the Salmonella organism quickly loses its infectious characteristics under normal test circumstances, making it difficult to study.
Researchers believe the environment of space can bring about key genetic changes in cells that affect the ability of the organism to invade human tissue and cause disease.
To induce these changes, worms will be grown from eggs on-board the
space shuttle. While in space, the worms will be fed Salmonella. The extent
of damage will be measured when the worms are returned to earth, helping to
identify which of the weakened strains is the most effective to use in a
vaccine.
'/>"/>
| SOURCE U.S. Department of Veterans Affairs Copyright©2008 PR Newswire. All rights reserved |